Treatment for Median Rhomboid Glossitis
For symptomatic median rhomboid glossitis, treat with oral fluconazole 100-200 mg daily for 7-14 days, as this condition is associated with candidal infection and responds well to systemic antifungal therapy.
Treatment Algorithm
First-Line Treatment for Symptomatic Lesions
When median rhomboid glossitis causes symptoms (pain, burning, irritation), initiate antifungal therapy based on the strong association with Candida albicans infection 1:
- Fluconazole 100-200 mg daily for 7-14 days is the preferred systemic treatment 2, 1
- This aligns with IDSA guidelines for oropharyngeal candidiasis, which recommend fluconazole as first-line therapy 2
- Resolution typically occurs within 2 weeks with appropriate antifungal treatment 3
Important Clinical Considerations
Topical antifungals (like nystatin) often fail in median rhomboid glossitis 3. If a patient has not responded to topical therapy, escalate to systemic fluconazole rather than continuing ineffective topical treatment. One case demonstrated complete resolution with fluconazole after nystatin failure 3.
Asymptomatic Lesions
No treatment is required for asymptomatic median rhomboid glossitis 1. Many patients have had these lesions since birth or for extended periods without complications. Patient education and reassurance about the benign nature of the condition is appropriate 4, 5.
When to Consider Alternative Approaches
If fluconazole fails or resistance is suspected:
- Consider molecular testing (PCR and pyrosequencing) to identify the specific Candida species and detect azole resistance mutations 3
- Alternative antifungals per IDSA guidelines include itraconazole solution 200 mg daily, posaconazole 400 mg daily, or voriconazole 200 mg twice daily 2
Address Contributing Factors
While treating with antifungals, counsel patients to:
- Discontinue tobacco smoking - strongly associated with median rhomboid glossitis 6
- Evaluate denture hygiene if applicable, as denture wearing contributes to candidal overgrowth 6
- Address any immunocompromising conditions that may predispose to persistent candidal infection
Common Pitfall to Avoid
Do not continue topical antifungals indefinitely when they are ineffective. The elevated, hyperplastic nature of median rhomboid glossitis lesions often prevents adequate penetration of topical agents 3, 6. Systemic therapy is more reliable for symptomatic cases.
Kissing Lesions
When median rhomboid glossitis presents with a corresponding "kissing lesion" on the palate (where the tongue contacts), treat both sites simultaneously with the same systemic antifungal regimen 7.